Devices › Device types
FDA product code MZF · class 2 · Microbiology
Test, hiv detection: medical device reports filed with FDA
3,206 reports carry this product code, 2002–2026; 10 brands with a page.
- 3,206
- reports with this product code
- 0% of all MAUDE reports
- 1,142
- reports, 12 months to August 2026
- 295 in the 12 months before
- 93.3%
- classified as malfunction
- 62.3% across all reports
- 0.1%
- classified as death, as reported
- 0.9% across all reports
Product code MZF is FDA's classification for "Test, hiv detection" (microbiology panel), a class 2 device. 3,206 medical device reports carry this product code, 0% of the MAUDE database, from December 2002 to August 2026.
1,142 reports arrived in the 12 months to August 2026, up 287% from 295 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (93.3%), injury (3.8%) and other (0.8%). 10 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| DETERMINE HIV-1/2 Ag/Ab COMBO 25T | 801 | 569 | 0% | 99.8% |
| Alere Determine Hiv 1/2 Ag/Ab Combo | 500 | 0 | 0.2% | 99.2% |
| Elecsys HIV Duo | 318 | 300 | 0% | 100% |
| Elecsys HIV combi PT | 226 | 193 | 0% | 99.6% |
| ARCHITECT HIV Ag/Ab Combo | 214 | 4 | 0.5% | 86.4% |
| Prism Hiv O Plus | 170 | 0 | 0% | 98.8% |
| Alere Determine Hiv-1/2 Ag/Ab Combo | 156 | 0 | 0% | 89.7% |
| Architect Havab Igm Reagent | 4 | 0 | 0% | 100% |
| Advia Centaur Xp | 1 | 1 | 0% | 94.9% |
| Architect I2000sr Analyzer | 1 | 0 | 0.1% | 95.2% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Abbott Diagnostics Scarborough | 997 | 31.1% |
| Roche Diagnostics | 504 | 15.7% |
| Abbott Germany | 209 | 6.5% |
| Abbott Laboratories | 164 | 5.1% |
| Abbott Molecular | 64 | 2% |
| Roche Molecular Systems - Branchburg | 64 | 2% |
| Abbott | 15 | 0.5% |
| Ortho-Clinical Diagnostics | 15 | 0.5% |
| Ortho Clinical Diagnostics | 2 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| False positive result | 2,162 | 67.4% |
| False negative result | 491 | 15.3% |
| Incorrect, inadequate or imprecise result or readings | 187 | 5.8% |
| Non reproducible results | 142 | 4.4% |
| Incorrect or inadequate test results | 80 | 2.5% |
| Low test results | 75 | 2.3% |
| High test results | 54 | 1.7% |
| Output problem | 27 | 0.8% |
| Improper or incorrect procedure or method | 17 | 0.5% |
| Leak/splashthe device leaked | 17 | 0.5% |
| Calibration error | 14 | 0.4% |
| Imprecise or erratic results | 9 | 0.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 7 | 0.2% |
| Insufficient device problem information | 6 | 0.2% |
| Incorrect measurementthe device measured wrongly | 5 | 0.2% |
| Nonstandard device | 5 | 0.2% |
| Unable to obtain readings | 4 | 0.1% |
| False reading from device non-compliance | 3 | 0.1% |
| Fluid/blood leak | 3 | 0.1% |
| Mechanical problema mechanical problem | 3 | 0.1% |
Questions about test, hiv detection reports
What is product code MZF?
FDA's classification code for "Test, hiv detection", class 2, reviewed by the microbiology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,206 reports through August 2026, 1,142 of them in the latest 12 months.
Which brands appear most often?
DETERMINE HIV-1/2 Ag/Ab COMBO 25T (801), Alere Determine Hiv 1/2 Ag/Ab Combo (500), Elecsys HIV Duo (318), Elecsys HIV combi PT (226) and ARCHITECT HIV Ag/Ab Combo (214). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.